|
|
Volumn 16, Issue 10, 2011, Pages 1451-1457
|
|
The european medicines agency review of tegafur/gimeracil/oteracil (teysuno™) for the treatment of advanced gastric cancer when given in combination with cisplatin: Summary of the scientific assessment of the committee for medicinal products for human use (CHMP)
a
|
|
Author keywords
EMA; European medicines agency; Gastric cancer; S 1; Tegafur gimeracil oteracil
|
|
Indexed keywords
5 (2 BROMOVINYL) 2' DEOXYURIDINE;
ALLOPURINOL;
CIMETIDINE;
CISPLATIN;
CLOZAPINE;
COUMARIN;
CYTOCHROME P450 2A6;
FLOXURIDINE PHOSPHATE;
FLUOROURACIL;
FOLINIC ACID;
GIMERACIL;
GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR;
METRONIDAZOLE;
MISONIDAZOLE;
OTERACIL;
PHENYTOIN;
SORIVUDINE;
TEGAFUR;
ABDOMINAL PAIN;
ADVANCED CANCER;
ALOPECIA;
ANEMIA;
ANOREXIA;
ASTHENIA;
BODY WEIGHT;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CHEMOTHERAPY INDUCED EMESIS;
COLORECTAL CANCER;
CONTINUOUS INFUSION;
CREATININE CLEARANCE;
DACRYOSTENOSIS;
DEHYDRATION;
DIARRHEA;
DOSAGE SCHEDULE COMPARISON;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG DOSE REGIMEN;
DRUG EXCRETION;
DRUG FATALITY;
DRUG METABOLISM;
DRUG SAFETY;
DRUG STRUCTURE;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
DRY EYE;
FATIGUE;
FEBRILE NEUTROPENIA;
FOOD;
FOOD DRUG INTERACTION;
GASTROINTESTINAL TOXICITY;
HAND FOOT SYNDROME;
HUMAN;
HYPOKALEMIA;
HYPONATREMIA;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
LACRIMATION;
LACRIMATION DISORDER;
LEUKOPENIA;
MELANOSIS;
MICROSATELLITE INSTABILITY;
MORNING DOSAGE;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEPHROTOXICITY;
NEUTROPENIA;
NONHUMAN;
OTOTOXICITY;
OVERALL SURVIVAL;
PANCYTOPENIA;
PERIPHERAL NEUROPATHY;
PHOSPHORYLATION;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RECOMMENDED DRUG DOSE;
REPEATED DRUG DOSE;
REPRODUCTIVE TOXICITY;
REVIEW;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
STOMACH ADENOCARCINOMA;
STOMACH CANCER;
STOMATITIS;
SURVIVAL TIME;
THROMBOCYTOPENIA;
VOMITING;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG APPROVAL;
EUROPEAN UNION;
HUMANS;
OXONIC ACID;
PRACTICE GUIDELINES AS TOPIC;
PYRIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
STOMACH NEOPLASMS;
TEGAFUR;
TREATMENT OUTCOME;
|
|
EID: 80054801482
PISSN: 10837159
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2011-0224 Document Type: Review |
|
Times cited : (29)
|
|
References (11)
|
